Your browser doesn't support javascript.
loading
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study.
Marabelle, Aurelien; Cassier, Philippe A; Fakih, Marwan; Kao, Steven; Nielsen, Dorte; Italiano, Antoine; Guren, Tormod Kyrre; van Dongen, Marloes G J; Spencer, Kristen; Bariani, Giovanni Mendonca; Ascierto, Paolo A; Santoro, Armando; Shah, Manisha; Asselah, Jamil; Iqbal, Syma; Takahashi, Shunji; Piha-Paul, Sarina A; Ott, Patrick A; Chatterjee, Arkendu; Jin, Fan; Norwood, Kevin; Delord, Jean-Pierre.
  • Marabelle A; Gustave Roussy, INSERM U1015, Université Paris Saclay, Villejuif, France. Electronic address: aurelien.marabelle@gustaveroussy.fr.
  • Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Fakih M; City of Hope National Medical Center, Duarte, CA, USA.
  • Kao S; Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
  • Nielsen D; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Italiano A; Early Phase Trials Unit, Institut Bergonié and University of Bordeaux, Bordeaux, France.
  • Guren TK; Oslo University Hospital, Oslo, Norway.
  • van Dongen MGJ; Antoni van Leeuwenhoek, Netherlands Cancer Institute Amsterdam, Amsterdam, Netherlands.
  • Spencer K; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Bariani GM; Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
  • Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Santoro A; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy; IRCCS Humanitas Research Hospital-Humanitas Cancer Center, Rozzano, Italy.
  • Shah M; Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Asselah J; McGill University, Montreal, QC, Canada.
  • Iqbal S; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Takahashi S; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Piha-Paul SA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ott PA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chatterjee A; Merck & Co, Kenilworth, NJ, USA.
  • Jin F; Merck & Co, Kenilworth, NJ, USA.
  • Norwood K; Merck & Co, Kenilworth, NJ, USA.
  • Delord JP; Institut Claudius Regaud IUCT-Oncopole, Toulouse, France.
Lancet Gastroenterol Hepatol ; 7(5): 446-454, 2022 05.
Article en En | MEDLINE | ID: mdl-35114169
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article